JFD01307SC
JFD01307SC is a glutamine synthetase inhibitor and anti-tuberculosis agent. JFD01307SC acts as a mimic of L-Glutamate and thus target enzymes involved in glutamine biosynthesis[1].
Product Specifications
CAS Number
[51070-56-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/jfd01307sc.html
Purity
98.0
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(O)CNC(CC1)CS1(=O)=O
Molecular Formula
C6H11NO4S
Molecular Weight
193.22
Precautions
H302, H315, H319, H335
References & Citations
[1]Gyanu Lamichhane, et al. Essential metabolites of Mycobacterium tuberculosis and their mimics. mBio. 2011 Feb 1;2 (1) :e00301-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human FBXL15 shRNA (UAS) - Lentiviral human FBXL15 shRNA (UAS, GFP) plasmid